49.35↑-0.20 (-0.40%)
12:00 AM,22nd Sep 202349.22↑-0.28 (-0.57%)
12:00 AM,22nd Sep 2023BSE : 524396
NSE : BIOFILCHEM
Sector : Health care
ISIN Code : INE829A01014
Last Updated: Sep 22 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 80 |
Turnover (₹ Cr) | 0.01 |
Volume (Shares) | 19338 |
Face Value | 10 |
52-WK High | 65.00 |
52-WK High Date | 26 Dec 2022 |
52-WK Low | 39.30 |
52-WK Low Date | 28 Mar 2023 |
All Time High | 356.10 |
All Time High Date | 14 Dec 2020 |
All Time Low | 0.55 |
All Time Low Date | 17 Jul 1998 |
Biofil Chemicals & Pharmaceuticals (BCPL) was incorporated as a private limited company on 4 Jan.'85 for manufacture of pharmaceutical products and it was converted into a public limited company on 7 May '92. It was promoted by the Systematix group and Ramesh Shah of the Cyano group. Ramesh Shah is the chairman and managing director and Anand Kumar Sethiya is the managing director. In Feb.'96 the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively both aggregating Rs 23.21 cr to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections capsules eye-drops and dry syrups at its plant located in Indore. BCPL's new unit is being set up at Pithampur in Madhya Pradesh at a project cost of Rs 39.75 cr and will manufacture bulk drugs like astemizole cefaclor pentazocine cefazolin sodium and cefotoxime sodium. It is also setting up a R&D centre which will include a pilot plant for bulk drugs and separate sections for formulations development and will house modern analytical instruments.During the year 1999-2000 the company had achieved a turnover of Rs.1164.03 lakhs.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 80 |
EPS - TTM (₹) [S] | 0.37 |
P/E Ratio (X) [S] | 4.64 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | 10.63 |
P/B Ratio (₹) [S] | 4.64 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 49.10 50.40 |
Week Low/High | 48.15 54.00 |
Month Low/High | 45.05 54.00 |
Year Low/High | 39.30 65.00 |
All time Low/High | 0.30 356.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -4.95% | -5.00% | -2.70 | -2.57% |
1 Month | 6.63% | 6.82% | 1.21 | 1.43% |
3 Month | 11.53% | 11.78% | 4.38 | 4.81% |
6 Month | 16.25% | 17.22% | 13.66 | 15.00% |
1 Year | -1.50% | -1.89% | 11.65 | 11.60% |
3 Year | -8.10% | -9.86% | 74.93 | 76.39% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
18-11-2022 | MOHINI DOSHI | NSE | SELL | 100349 | 59.11 |
18-11-2022 | MOHINI DOSHI | NSE | BUY | 100349 | 59.23 |
18-11-2022 | SILVER LINE VENTURES PRIVATE LIMITED | NSE | SELL | 97004 | 59.18 |
18-11-2022 | SILVER LINE VENTURES PRIVATE LIMITED | NSE | BUY | 97004 | 58.67 |
11-01-2022 | ALPHA LEON ENTERPRISES LLP | NSE | BUY | 125119 | 97.40 |
11-01-2022 | ALPHA LEON ENTERPRISES LLP | NSE | SELL | 134457 | 97.75 |
11-01-2022 | DB (INTL) OWN TRADING | BSE | BUY | 25405 | 96.60 |
11-01-2022 | DB (INTL) OWN TRADING | BSE | SELL | 83403 | 97.59 |
11-01-2022 | DB INTERNATIONAL STOCK BROKERS LIMITED | NSE | SELL | 25405 | 96.60 |
11-01-2022 | DB INTERNATIONAL STOCK BROKERS LIMITED | NSE | BUY | 83403 | 97.40 |
Load More |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 46.82 |
Financial Institutions Banks | 0.04 |
Foreign Institutional Investors | 0.00 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 0.00 |
Other Institutional Investors | 0.04 |
Indian Public | 38.10 |
Others Non Institutional Investors | 15.00 |
Custodians | 0.00 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Chairman & Managing Director : Ramesh Shah
Director : Romil Shah
Independent Director : Shaila Jain
Independent Director : Satish Beohar
Independent Director : Ashok Kumar Ramawat
Whole-time Director : Ketan Shah
Company Sec. & Compli. Officer : Shweta Verma
Registered Office: 11/12 Sector E Sanwer Road, Sanwer Road Industrial Area,Indore,Madhya Pradesh-452015 Ph: 91-731-2426700
Email:bcplcompliance@gmail.com